Prescrire International - Free Special Edition - 2022

Prescrire is a French non-profit continuing education organisation, committed to better patient care Prescrire International is a monthly journal on new drugs authorised in Europe with selected texts from La Revue Prescrire Who are we?

INTERNATIONAL

eng l i sh . prescr i re . org

President of Association Mieux Prescrire: Antoinne Grandvuillemin, pharmacist ASSOCIATIONMIEUXPRESCRIRE “Towork, inall independence, infavourof quality healthcare, first and foremost intheinterest ofpatients(...)” (Article 1 of the Association Mieux Prescrire bylaws). Prescrire International is published 11 times a year byAssociation Mieux Prescrire, a non-profit continuing education organisation (N° 11 711 075) under the French lawof 1901. EDITORIALSTAFF Members of the Prescrire Editorial Staff sign a yearly declaration of absence of conflicts of interest, in accordance with Prescrire’s “Non merci...” Charter. Members are free from any interest contrary to Association Mieux Prescrire’s objectives (the Charter and the Declaration are available online at english. prescrire.org). Publishing reliable reviews that are easy to use and adapted to readers’ needs depends upon complex editorial procedures, all initiated and overseen by the members of Prescrire’s Editorial Staff. Members of the Editorial Staffdefine editorial goals. They oversee the literature search, the writing and rewriting of texts, and the review by a panel of outside experts (medical specialists, methodologists, representatives of Prescrire’s subscriber base…). They organise internal and external quality control procedures, and edit the final copy. Every draft is submitted, before publication, to a large number of external reviewers. Around 250 people participate in the production and distribution of every issue of La Revue Prescrire , including: -  around 150members of the Prescrire team ; -  around 100 external reviewers, experts in the subjects discussed and practising healthcare professionals. For each issue, readers are provided with a list of the contributors to that issue.

drugs and therapeutic and diagnostic strategies. Association Mieux Prescrire publishes a monthly journal inFrench, andanedition in English 11 times a year. A non-profit organisation, Prescrire is wholly financed by subscribers, and accepts no advertising or other outside support. Reliable and relevant content Prescrire has the editorial and research capabilities necessary to ensure the accuracy of its reviews. Most of Prescrire’s editors are healthcare professionals, specially trained in Prescrire’s editorial methodsandfreefromconflictsof interest. Exacting quality-control procedures are applied to all editorial content.

The Association Mieux Prescrire (AMP), a non-profit organisation registered under the French law of 1901, manages all of Prescrire’s programmes and publications. TheAMPis structuredsoastobefreeofany influencefrompharmaceutical companies or healthcare institutions. Independent information Prescrire’s purpose is stated in Article 1 of the AMP bylaws: “To work, in all inde- pendence, infavourofqualityhealth-care,first and foremost in the interest ofpatients (...).” Prescrire offers continuing education specifically adaptedtotheneedsofhealth care professionals. Since 1981, Prescrire has provided healthcare professionals – and via them, patients – with the clear, comprehensive and reliable information they need about

Subscribers can download any of the thousands of detailed reviews produced by Prescrire’s multidisciplinary team, and all including complete notes and references. All are available instantly , via an online table of contents going back to 1992, or via a search function.

SUBSCRIBE NOWFOR FULL ACCESS

TO ONLINE CONTENT

Copyright Prescrire www.prescrire.org Registered address: 83, bd Voltaire 75011 Paris France Tel.: +33 1 49 23 72 80 E-mail: contact@prescrire.org Postal address: Prescrire - 83, bd Voltaire 75558 PARIS CEDEX 11 - FRANCE

Prescrire is a founder andmember of the International Society of Drug Bulletins (ISBD), a worldwide network of bulletins and journals on drugs and therapeutics

Reliable, rigorously independent information, on drugs authorised in Europe. No grants, no advertising. No shareholders, no sponsors. Prescrire is financed by subscribers.

NO GRANTS NO ADVERTISING NO CONFLICTS OF INTEREST

that are financially and intellectually independent of pharmaceutical industry. The overall aimof ISDB is to encourage and assist the development of independent drug bulletins and to facilitate

cooperation amongst them. Website: www.isdbweb.org

Printed by Bulls Market Group/TPI